Search results
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 5 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Allogene secures $15 million grant for cancer trial By Investing.com
Investing.com· 1 day agoThe TRAVERSE trial follows the Fast Track Designation granted by the...Administration in March 2022,...
The Top 3 Biotech Stocks to Buy in April 2024
InvestorPlace· 10 hours agoBiotech stocks are notorious for being some of the most volatile and unpredictable on the market. With clinical trials and FDA approvals creating...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 3 days agoOverall, 27.3% responded to the treatment. A total of 63.6% of patients had their disease under...
New study provides genomic insights into kidney cancer risk
National Cancer Institute· 2 days agoIn a new analysis of genetic susceptibility to kidney cancer, an international team of researchers...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 3 days agoThe NDA is supported by results from JUPITER-02, a randomized, double-blind, placebo-controlled, multinational...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
KLAS Las Vegas· 3 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoOutside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days agoNew York, USA, April 24, 2024 (GLOBE NEWSWIRE) -- HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the growth of the HDAC inhibitors market is expected
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoMerck, with multiple facilities in eastern Pennsylvania and New Jersey, also delivered good news...
